Search for Experiment

Included Properties

Data Type
  • Experiment5692
    • Project
    Lab
    Experiment Type
    Organism
    Sample Type
    Biosource
    Modifications
    Treatments
    Publications
    Center
    Microscopy Technique
    Type
  • ExperimentSetReplicate5692
    • experimentset_type
  • replicate5692
    • Status
    Commendations
    Warnings
    5692 Results
    Title
    Type
    Organism
    Biosource Type
    Biosource
    Enzyme
    Crosslinking Method
    Modifications
    Treatments
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEX6MEJJCE
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (10.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXCXXBQW2
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (10.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXF9ETX7N
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (8.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXQRMGL2H
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (8.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXVNEO5N1
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (6.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXAOL1SW2
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (6.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEX47LGRSB
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), dTAGv-1 treatment (500.0 nM, 8.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEX75JGE7B
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), dTAGv-1 treatment (500.0 nM, 8.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXJX5VFPF
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), dTAGv-1 treatment (500.0 nM, 6.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXC7XBMXY
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), dTAGv-1 treatment (500.0 nM, 6.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXQTYNJJ1
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), dTAGv-1 treatment (500.0 nM, 4.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEX9OWDBSL
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), dTAGv-1 treatment (500.0 nM, 4.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXBHXXC3G
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (4.0h), 4-thiouridine treatment (100.0 μM, 120.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXFQHY41S
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (4.0h), 4-thiouridine treatment (100.0 μM, 120.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXINLCZCR
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (4.0h), 4-thiouridine treatment (100.0 μM, 120.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXAQ61XCL
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), dTAGv-1 treatment (500.0 nM, 120.0m), 4-thiouridine treatment (100.0 μM, 120.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXBW9M4YW
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), dTAGv-1 treatment (500.0 nM, 120.0m), 4-thiouridine treatment (100.0 μM, 120.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXNTUVFDY
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), dTAGv-1 treatment (500.0 nM, 120.0m), 4-thiouridine treatment (100.0 μM, 120.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXG6NQEXJ
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (4.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEX22REYWB
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (4.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXKTQ1W16
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (4.0h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXNAC6VG9
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (3.5h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXUJDIYT1
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (3.5h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXWSVT1OX
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (3.5h), 4-thiouridine treatment (100.0 μM, 15.0m)
    SLAM-seq on dTAG-NIPBL hTERT-RPE-1 - clone D7 - 4DNEXUGCVZU1
    ExperimentSeq
    Human
    immortalized cell line
    dTAG-NIPBL hTERT-RPE-1 - clone D7
    -
    -
    -
    Thymidine treatment (2.0 mM, 14.0h), Nocodazole treatment (20.0 ng/mL, 2.0h), DMSO treatment (3.0h), 4-thiouridine treatment (100.0 μM, 15.0m)